1. Home
  2. BCYC vs ADTN Comparison

BCYC vs ADTN Comparison

Compare BCYC & ADTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • ADTN
  • Stock Information
  • Founded
  • BCYC 2009
  • ADTN 1985
  • Country
  • BCYC United Kingdom
  • ADTN United States
  • Employees
  • BCYC N/A
  • ADTN N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • ADTN Telecommunications Equipment
  • Sector
  • BCYC Health Care
  • ADTN Telecommunications
  • Exchange
  • BCYC Nasdaq
  • ADTN Nasdaq
  • Market Cap
  • BCYC 896.2M
  • ADTN 831.1M
  • IPO Year
  • BCYC 2019
  • ADTN 1994
  • Fundamental
  • Price
  • BCYC $11.66
  • ADTN $10.84
  • Analyst Decision
  • BCYC Buy
  • ADTN Strong Buy
  • Analyst Count
  • BCYC 9
  • ADTN 4
  • Target Price
  • BCYC $33.25
  • ADTN $12.75
  • AVG Volume (30 Days)
  • BCYC 295.8K
  • ADTN 1.1M
  • Earning Date
  • BCYC 03-04-2025
  • ADTN 02-26-2025
  • Dividend Yield
  • BCYC N/A
  • ADTN N/A
  • EPS Growth
  • BCYC N/A
  • ADTN N/A
  • EPS
  • BCYC N/A
  • ADTN N/A
  • Revenue
  • BCYC $36,898,000.00
  • ADTN $905,347,000.00
  • Revenue This Year
  • BCYC $41.07
  • ADTN N/A
  • Revenue Next Year
  • BCYC N/A
  • ADTN $10.44
  • P/E Ratio
  • BCYC N/A
  • ADTN N/A
  • Revenue Growth
  • BCYC 48.60
  • ADTN N/A
  • 52 Week Low
  • BCYC $11.14
  • ADTN $4.34
  • 52 Week High
  • BCYC $28.67
  • ADTN $12.16
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 34.58
  • ADTN 51.86
  • Support Level
  • BCYC $11.14
  • ADTN $10.71
  • Resistance Level
  • BCYC $13.11
  • ADTN $12.16
  • Average True Range (ATR)
  • BCYC 0.69
  • ADTN 0.56
  • MACD
  • BCYC 0.08
  • ADTN -0.04
  • Stochastic Oscillator
  • BCYC 22.32
  • ADTN 41.33

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

About ADTN ADTRAN Holdings Inc.

Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support Segment which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions.

Share on Social Networks: